Dexamethasone promotes renal fibrosis by upregulating ILT4 expression in myeloid‐derived suppressor cells

Abstract Studies have shown that adoptive transfer of myeloid‐derived suppressor cells (MDSCs) can alleviate various inflammatory diseases, including glomerulonephritis, but the long‐term effects of the transferred MDSCs are still unclear. In addition, although glucocorticoids exert immunosuppressive effects on inflammatory diseases by inducing the expansion of MDSCs, the impact of glucocorticoids on the immunosuppressive function of MDSCs and their molecular mechanisms are unclear. In this study, we found that adoptive transfer of MDSCs to doxorubicin‐induced focal segmental glomerulosclerosis (FSGS) mice for eight consecutive weeks led to an increase in serum creatinine and proteinuria and aggravation of renal interstitial fibrosis. Similarly, 8 weeks of high‐dose dexamethasone administration exacerbated renal interstitial injury and interstitial fibrosis in doxorubicin‐induced mice, manifested as an increase in serum creatinine and proteinuria, collagen deposition and α‐SMA expression. On this basis, we found that dexamethasone could enhance MDSC expression and secretion of the fibrosis‐related cytokines TGF‐β and IL‐10. Mechanistically, we revealed that dexamethasone promotes the expression of immunoglobulin‐like transcription factor 4 (ILT4), which enhances the T‐cell inhibitory function of MDSCs and promotes the activation of STAT6, thereby strengthening the expression and secretion of TGF‐β and IL‐10. Knocking down ILT4 alleviated renal fibrosis caused by adoptive transfer of MDSCs. Therefore, our findings demonstrate that the role and mechanism of dexamethasone mediate the expression and secretion of TGF‐β and IL‐10 in MDSCs by promoting the expression of ILT4, thereby leading to renal fibrosis.